News
Rivian stock drops as Q2 earnings miss expectations and 2025 loss forecast widens amid EV tax credit blow and tariffs: The electric truck maker reported mixed Q2 2025 earnings, delivered fewer ...
All told, the S&P 500 rose 91.93 points to 6,329.94. The Dow Jones Industrial Average climbed 585.06 to 44,173.64, and the ...
StockStory.org on MSN1h
Latham (NASDAQ:SWIM) Misses Q2 Sales Targets
Residential swimming pool manufacturer Latham (NASDAQ:SWIM) in Q2 CY2025, but sales rose 7.8% year on year to $172.6 million.
StockStory.org on MSN1h
Zeta (NYSE:ZETA) Surprises With Strong Q2, Stock Soars
Advertising and marketing company Zeta Global (NYSE:ZETA) reported in Q2 CY2025, with sales up 35.4% year on year to $308.4 ...
StockStory.org on MSN1h
QuidelOrtho’s (NASDAQ:QDEL) Q2 Earnings Results: Revenue In Line With Expectations, Stock Soars
Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) in Q2 CY2025, but sales fell by 3.6% year on year to $613.9 million.
StockStory.org on MSN1h
Toast’s (NYSE:TOST) Q2: Beats On Revenue
Restaurant software platform Toast (NYSE:TOST) announced in Q2 CY2025, with sales up 24.8% year on year to $1.55 billion. Its GAAP profit of $0.13 per share was 22.8% above analysts’ consensus ...
StockStory.org on MSN1h
Assurant (NYSE:AIZ) Posts Better-Than-Expected Sales In Q2
Insurance services company Assurant (NYSE:AIZ) reported Q2 CY2025 results , with sales up 8% year on year to $3.16 billion. Its non-GAAP profit of $5.10 per share was 14.5% above analysts’ consensus ...
The ISM report showed service sector activity in June flatlined while the prices paid index rose to its highest in nearly ...
StockStory.org on MSN1h
Qualys (NASDAQ:QLYS) Exceeds Q2 Expectations, Stock Soars
Cloud security and compliance software provider Qualys (NASDAQ:QLYS) reported in Q2 CY2025, with sales up 10.3% year on year ...
StockStory.org on MSN2h
Vestis (NYSE:VSTS) Posts Q2 Sales In Line With Estimates
Uniform rental provider Vestis Corporation (NYSE:VSTS) in Q2 CY2025, but sales fell by 3.5% year on year to $673.8 million.
U.S. stocks have stumbled since the start of August, and a number of Wall Street strategists are warning that this might be just a taste of a deeper selloff ahead.
StockStory.org on MSN2h
Myriad Genetics (NASDAQ:MYGN) Reports Strong Q2, Stock Jumps 30.6%
Genetic testing company Myriad Genetics (NASDAQ:MYGN) reported in Q2 CY2025, but sales were flat year on year at $213.1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results